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D 4.9
Infrainguinal Disease-Endovascular Treatment
As with other interventions for CLI, the purpose of
PTA is to salvage a functioning foot. Late restenosis or
occlusion after PTA may result in recurrent ulceration
in some patients,' but it rarely precludes subsequent
surgery or compromises additional vascular seg-
ments. PTA can spare saphenous vein for later use in
the ipsilateral limb, the contralateral limb, or the coro-
nary circulation.
The categorical indications for endovascular treat-
ment, based on clinical symptoms, include patients in
the grade I (severe claudication) grade II (rest pain),
and grade III (tissue loss) of the Rutherford classifica-
tion, For limb salvage indications, the effectiveness of
transluminal angioplasty of the femoropopliteal arter-
ies and the tibioperoneal arteries should be considered
together rather than separately. This is because most
patients with rest pain and tissue loss will have multi-
segment occlusive disease, and effective treatment of
both segments may be necessary to alleviate signs and
symptomsP Furthermore, effective restoration of
tibioperoneal artery blood flow is believed by some to
increase the durability of femoropopliteal artery
angloplasty.- Unfortunately, few series have analysed
PTA of the femoropopliteal and tibial segments
together.v-? Angioplasty techniques have improved
with time, allowing for technically successful percuta-
neous recanalisation of virtually all short lesions.8,9,lo
However, appropriate selection of anatomically suit-
able lesions remains the key to achieving acceptable
results in patients with infrainguinal occlusive disease
and chronic limb-threatening ischaemia (see
Recommendation 34, p 588).
D 4.9.1
Factors Affecting the Outcome of Femoropopliteal
Angioplasty
Percutaneous transluminal angioplasty has been
applied to the superficial femoral and popliteal artery
segments for almost 35 years. Confusion and contro-
versy still exist concerning outcomes, because often
the reporting of indications and results has not been
standardised, and statistical analysis has not been
optimal. Varying the reporting criteria has been
shown to result in as much as a twofold difference in
reported 5-year patency," Many reported studies suf-
fer from grouping of claudication and limb salvage
patients; others from failure to stratify results.P and
still others from describing early experiences that
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antedate the latest developments in low-profile bal-
loon catheters and steerable, soft-tipped guide-
wires.13,14
Claudication versuschronic critical limb ischaemia
Despite the grouping of claudication and limb salvage
patients in most femoropoplitcal PTA series, analysis
of subsets from these studies allows the clinical effec-
tiveness of the method to be estimated in patients with
chronic CLI.
Lesion lengtli
Currently, virtually all short femoropopliteal artery
stenoses and occlusions can be percutaneously
recanalised. Still, long lesion length is considered one
of the factors detracting from both technical success
and durability of femoropopliteal PTA.15,16,17,18
Although recent analyses often include a preponder-
ance of patients with longer lesions,5,18,19,2o PTA of
lesions longer than 7 to 10 ern offers limited potency,
16,18 whereas those 3cm in length or smaller fare well
with PTA.15,21
Stenosis versusocclusion
This variable was previously considered to be one of
the most important determinants of both technical
success and durability of femoropopliteal PTA.
Importantly, most symptomatic patients with
femoropopliteal disease presenting for angiography
have occlusions rather than stenoses. Technical fail-
ures, though uncommon, usually result from failure to
cross the lesion with a guidewire and occur almost
exclusively in cases of occlusion. Still, approximately
up to 90% of lesions up to 10 ern in length can be suc-
cessfully traversed and dilated8,22 and even a higher
percentage success rate with longer lesions has been
achieved.v Nevertheless, relative to stenoses, there is a
difference in technical success that lowers the starting
point of the life-table patency curve for occlusions.
However, once an occlusion is crossed with a
guidewire and successfully dilated, it generally
exhibits the same expected patency as that of a steno-
sis of equivalent length, if all other factors are equal
(ie, the life-table curves are parallel).15,16,23,24 This means
that occlusion is a confounding variable that lowers
the initial technical success but that has no other estab-
lished impact on long-term patency.
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Other target lesion morphological determinants
Concentric lesions respond better than eccentric
lesions to PTA initially, and heavy lesion calcification
appears to exert a negative effect on success.15.16Post-
angioplasty residual stenosis predicts limited dura-
bility, and whether duplex ultrasonography is a
modality useful for making this determination is
controversial.25;l.6;l.7
Runof]status
One of the most powerful predictors of long-term
success that has great relevance in patients with
chronic CLI is the status of the runoff circulation.
Patients with two- to three-vessel run-off have as
much as two to three times greater femoropoliteal
PTA patency than those with 0- to one-vessel run-off
at 2 to 3 years (71% to 78% vs 25% to 37%, respec-
tively)17.21 and at 5 years (36% to 53% vs 16% to 31%,
respectivelyj.e A retrospective analysis of the litera-
ture with attention to run-off status indicated 3- and
5-year patency results of 67% and 62%, respectively,
for femoropopliteal stenosis and good run-off; 53%
and 48%, respectively, for occlusion and good runoff;
49% and 43%, respectively, for stenosis and poor run-
off; and 32% and 27%, respectively, for occlusion and
poor run-off.t?
Patient factors
Patient factors widely believed to adversely influ-
ence femoropopliteal artery PTA success are the pres-
ence of diabetes mellitus and presentation for PTA
with CLI rather than claudication.19.21,28,30 However, it
is likely that the effects of diabetes and CLI are sta-
tistically confounded by run-off status and the extent
of occlusive disease. Diabetic patients with good run-
off fare better than those with poor run-off after
femoropopliteal PTA,31 Diabetic patients in whom
continuous run-off can be restored by tibioperoneal
PTA also fare well.v It is also likely that patients with
end-stage renal disease fare worse than the angio-
plasty population as a whole, because of a combina-
tion of vascular anatomic factors and local metabolic
factors; these patients have been inadequately strati-
fied in the PTA literature and may constitute up to
8% to 10% of the limb salvage population in some
institutions.3
SlImmary offactors affeclillg tileoutcome of
[entoropopliieal allgioplasty
Thus, although some have attempted to place a single
value or range of values on the results of
femoropopliteal PTA, its efficacy is highly dependent
on anatomic selection and, to a lesser extent, patient
selection. For patients with CLI, it is likely that only a
minority-perhaps 5% to 35%-are candidates . for
PTA if selected for favourable anatomy.2.10,3J,3.J,35 PTA of
proximal popliteocrural obstructions to improve flow
to collateral vessels in the absence of straight-line flow
to the foot will not help patients.v Laser-assisted
angioplasty and rotablator atherectomy of crural
arteries does not improve the technical and clinical
results as compared with PTA alone.28,36,37,38,39AO.~I.~2.U
There is no body of published data on the use of laser-




The results of several large studies are summarised in
Table 21, Endovascular Procedures for Intermittent
Claudication (p 589). (See B 4.3.4, Femoropopliteal
PTA, p 588; B 4.3.5, Femoropopliteal Stents, p 591.)
They are presented in the intermittent claudication
section because this indication dominates the data
(72% of subjects in the studies cited were patients with
intermittent claudication). These listed results must be
viewed with caution, because infrainguinal angie-
plasty depends heavily on patient selection factors.
Nevertheless, by analysing subsets of patients
described in these studies and others, one can estimate
the clinical effectiveness of infrainguinal PTA per-
formed in patients with chronic CLI.
Table 22 (p 591) shows the results from selected
studies by lesion length cut-off point. Again these
results are presented in the intermittent claudication
section because this indication dominates the data.
Jeans et aPI found that stenoses smaller than 1 em
fared significantly better than lesions larger than 1 ern
at 5 years (primary patency, 76% vs. 50%, P < 0.05).2\
Durability of femoropopliteal PTA in a subgroup of 37
patients with stenoses and two- to three-vessel run-off
was 78% at 3 years (5E ± 9.4%); by contrast, occlusions
with poor runoff showed a 25% patency rate. Krepel et
al i5 stratified results on durability and found that
stenoses smaller than 2 em fared better at 5 years than
stenoses longer than 2 ern (primary patency, 77% vs.
54%), whereas 'l-year patency rates with occlusions
smaller than 3 em was 93%, versus only 50% in occlu-
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sions larger than 3 em 15 Gallino et al 17 found that
patients with occlusions larger than 3 em and poor
distal run-off had elevated reocclusion rates compared
with those who had focal stenoses or occlusions small-
er than 3 em and two- to three-vessel runoff (primary
patency, 37% vs 71% at 2 years).'? Currie et alH defined
lesions with a 5-cm cutoff; at 6 months, 10 of 17 short
occlusions or stenoses were patent (59%), whereas
only 1 of 23 long lesions were patent (4%).
Unfortunately, there was a 22% technical failure rate in
this series, and the authors did not assess the effect of
run-off on patency."
In comparing 0- to 2-cm and 2- to 5-cm lesions with
those larger than 10 em, Capek et al16 found highly sig-
nificant differences in success (p =0.007, P = 0.015).
There were also strong statistical trends when 0- to 2-
em lesions were compared with 2- to 5-cm and 5- to
Ill-em lesions (p = 0.10, P = 0.06). Capek et al were
unable to utilise Cox multivariate regression because
of sample size so they were unable to simultaneously
analyse any run-off effect on these stratified groups."
Murray et al, dividing his patients at 7 em, found that
only 23% of long femoropopliteal artery PTA were
patent at 6 months.P Because power estimates were
not given, it is likely that some nonsignificant differ-
ences were due to small sample size.
Adiunctiue liseofstents ill[cmoropopliteal lesions
The preponderance of patients in published series of
femoropopliteal stents have been patients with inter-
mittent claudication, and although technical success is
high, restenosis rates are considerable. Reported mean
stenosis rates are 30% at 1 year (range, 19% to 53%)
and 40% at 3 years (range, 28% to 82%) (see Table 23,
p 591; Table 24, p 593). This series does not stratify
durability by clinical indication. Restenosis rates
appear to be higher in distal femoropopliteal seg-
ments or when lesions require multiple stents.45•46 Poor
outflow and long occlusions appear to increase the fre-
quency of stent thrombosis.v-v
Because limb salvage indications are associated
with poor run-off and more diffuse disease,
femoropopliteal stents probably do worse in CLI
patients than in intermittent claudication, and they
would be expected to fare worse than the aggregate
published stent population. However, there is accu-
mulating evidence that stents can play an important
role in rescuing failed femoropopliteal PTA attributa-
ble to PTA-induced dissection, elastic recoil, or throrn-
bosis.49,50,51 There is little published evidence regarding
the efficacy of tibial artery stents.
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type A lesions, and surgenJ is the procedure of clioice




The universally accepted indication for infrapopliteal
artery PTA is limb salvage. Some reported series have
comprised a significant proportion of claudica-
tors.4,52,64 Infrapopliteal PTA can be used to salvage
failing distal bypass grafts by restoring tibial artery
outflow.v A number of published reports have shown
increased durability of femoropopliteal PTA in
patients with good distal run-off; thus, some authors
have recommended tibial angioplasty as an adjunct to
femoropopliteal PTA performed for either claudica-
tion or limb salvage when calf run-off is poor. 4
Diabetes and end-stage renal disease
Diabetes is present in 63% to 91% of patients undergo-
ing tibial angioplasty for limb salvage indications.
Although most of these patients present with three-
vessel calf occlusive disease, there is usually reconsti-
tution of at least one pedal artery. Patients with end-
stage renal disease (who are often diabetic) appear to
be the most difficult group to treat because they have
very diffuse disease with more involvement of the dis-
tal and pedal vessels, and because there is heavier
arterial calcification. The presence of end-stage renal
disease (E5RD) probably has a negative prognostic
effect on the durability of tibial and femoropopliteal
PTA, but it has not been accounted for in published
angioplasty series.3,53
Cardiooascular contorbiditu
The median age of patients undcrgoing tibial anglo-
plasty in published series is approximately 69 years.
These high-risk patients almost always have associat-
ed cardiac or cerebrovascular disease: hypertension,
chronic renal insufficiency, and history of TIA or
stroke are common." Five-year survival in patients
with limb salvage indications for surgical or percuta-
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Table 51: Results of PTA in infrapoplileallesions (from a review by Wagner & Rager»)
CLI Diabetes Technical % Limb salvage
Author Limbs (%) (%) success (%) (follow-up period)'
Schwarten & Cutcliff, 198810 114 100 60 97 86 (24 mol
Lofberg et al, 199656 86 100 74 88 75 (24 rna)
Matsi et al, 19935 84 100 77 83 52 (24 mol
Hauser et al, 199657 47 100 93 80 77 (24 rna)
Saab et al, 199238 14 100 69 100 79 (19 mol
Buckenham et al, 199359 14 100 38 100 85 (8 rna)
Durham et al, 199460 14 100 100 100 77 (17 mol
Brown et al, 198861 11 100= 91 82 73 (8 rna)
Bakal et al, 199()32 57 98 85 78 NA
Wagner & Klose, 1997°2 87 93 64 92 71 (12 rna)
Brown et al, 1993&3 55 84 64 95 53 (24 mol
Bull ct al, 199204 168 76 52 100 85 (24 rna)
Bolia et al, 199465 24 71 43 86' NA
Wagner et al, 19937 158 68 46 95 88 (17mo)
Starck et al, 198437 46 67 NA 76 NA
Dorros et al, 199006 lSI 53 46 90 NA
Sivanathan et al, 19946 41 53 13 96 NA
Varty et al, 199552 40 50 45 98 77 (12 rna)
Horvath et al, 19904 71 42 35 96 NA
'Subintimal angioplasty.
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neous intervention is only approximately 50%; mor-
tality is usually attributable to coronary artery disease
or stroke.? The procedure-related mortality is lower
with PTA than with bypass surgery. More than 1,200
patients are reported in the Iiterature.v
Lesion lengthand run-of]status
The ideal tibial lesion is focal, with good run-off dis-
tally. Stenoses appear to have a better technical success
rate than occlusions. Only approximately 20% to 30%
of patients with tibial disease have anatomy
favourable for PTA.3·1O Severe three-vessel disease is
nearly universal in limb salvage patients; anatomy
favourable for tibial PTA, if present, is usually seen in
one or two vessels. A concomitant procedure, usually
femoropopliteal artery PTA, is necessary in most
patients undergoing tibial angioplasty because of the
predominance of multilevel occlusive disease; thus,
the results of femoropopliteal PTA and tibial PTA are
closely associated. Restoration of straight-line flow to
the pedal arch by PTA in one or more tibial arteries is
necessary for clinical success; dilatation of a proximal
lesion when the distal artery is severely diseased will
not yield lasting clinical benefit in limb salvage
patients.32. 63. 6-l This finding has since been corroborat-
ed by others. Crural disease in patients with long-
standing diabetes may, in rare cases, be the sale deter-
minant of CLI, despite the absence of aortoiliac or
femoropopliteal disease. A small subset of these
patients may be suitable for PTA. It is probable that
the status of the pedal arch-never looked at in
infra inguinal angioplasty studies-also affects the
outcome of distal angioplasty. Careful patient selec-
tion is thus important for both technical and clinical
success.
Results of endouascular treatment of infrapoplitenl lesions
Recent published technical success rates of
infrapopliteal artery PTA using small vessel balloons
have been excellent, between 86% and 100%. Major
complications have been reported in 2% to 6% of
cases, most frequently puncture site haematomas and
vessel occlusions. Iatrogenic vascular occlusion usu-
ally responds to local thrombolysis. Limb salvage has
been reported to be between 60% and 86% at 2 years
and appears to be dependent on anatomic factors.
For example, Bakal et aP2 found an 80% limb salvage
rate in patients with "straight line flow" to the foot
in at least one tibial vessel after PTA, whereas limb
salvage fell to 0% when distal outflow was obstruct-
ed.32 In a later group of patients at the same institu-
tion, infrainguinal PTA performed for long-segment,
more diffuse disease in patients with poor 'surgical
options had a I-year primary patency as low as 15%,
confirming the need for careful anatomic selection.
Appropriate post-PTA surveillance with secondary
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intervention appears to significantly prolong the
patency of tibial PTA.52
In recent years, several reports with sufficient
long-term follow-up of PTA in infrapopliteal lesions
have appeared in the literature (Table 51). Only tech-
nical success and limb salvage figures are given,
because patency of one of three crural vessels is
impossible to determine by ABPI or other indirect
measurements, especially because proximal revascu-




Substantial experience demonstrating the effective-
ness and safety of infrainguinal angioplasty has been
accumulated. Although differences in reporting make
it difficult to easily estimate the true effectiveness of
infrainguinal PTA, a consensus about its effectiveness
can be obtained by critical analysis of. the existing
reports. Technical success rates now approach 95% to
100%. Anatomic selection is most important. Patients
with focal disease and restorable runoff will generally
benefit; conversely, patients with diffuse disease and
poor run-off will not. Unfortunately, because of the
presence of diffuse disease in chronic CLI, endovascu-
lar techniques are only applicable in a small portion of
CLI patients. For femoropopliteal PTA, 50% to 77% of
anatomically selected patients will show clinical bene-
fit at 2 years. Tibial PTA has generally been reserved
for limb salvage patients, and with appropriate
patient selection, 2-year limb salvage rates of approxi-
mately 80% can be expected. Close surveillance and
early reintervention will probably increase the effec-
tiveness of percutaneous treatment methods.
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